SynthesisFrontiers in immunology2026

Infection risk associated with talquetamab in relapsed/refractory multiple myeloma: a systematic review with meta-analysis of talquetamab monotherapy and descriptive analysis of combination therapy.

Zeng-Yi Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.